ANIK
Anika Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANIK Filings
Filing Date
Form Description
Form Type
2025-11-21
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-21 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-05
Anika Therapeutics, Inc. (ANIK) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-05 · Earnings Call
Anika Therapeutics, Inc. (ANIK) Q3 2025 Earnings Call Transcript
2025-11-05
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-11-05 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-11-05
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-05 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-05
Form 8-K - Current report
Key Events
2025-11-05 · Key Events
Form 8-K - Current report
2025-10-17
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-17 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-07-30
Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript
Earnings Call
2025-07-30 · Earnings Call
Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript
2025-07-30
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-07-30 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-07-30
Form 8-K - Current report
Key Events
2025-07-30 · Key Events
Form 8-K - Current report
